GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vincent Medical Holdings Ltd (HKSE:01612) » Definitions » EBIT

Vincent Medical Holdings (HKSE:01612) EBIT : HK$79.3 Mil (TTM As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Vincent Medical Holdings EBIT?

Vincent Medical Holdings's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was HK$34.6 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$79.3 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Vincent Medical Holdings's annualized ROC % for the quarter that ended in Jun. 2024 was 14.51%. Vincent Medical Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 21.82%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Vincent Medical Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 32.43%.


Vincent Medical Holdings EBIT Historical Data

The historical data trend for Vincent Medical Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vincent Medical Holdings EBIT Chart

Vincent Medical Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 287.48 68.61 -12.66 68.60 79.34

Vincent Medical Holdings Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.52 33.32 35.28 34.57 44.77

Competitive Comparison of Vincent Medical Holdings's EBIT

For the Medical Devices subindustry, Vincent Medical Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vincent Medical Holdings's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vincent Medical Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Vincent Medical Holdings's EV-to-EBIT falls into.


;
;

Vincent Medical Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$79.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vincent Medical Holdings  (HKSE:01612) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Vincent Medical Holdings's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=68.488 * ( 1 - 0.88% )/( (501.945 + 433.859)/ 2 )
=67.8853056/467.902
=14.51 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=786.609 - 108.88 - ( 175.784 - max(0, 236.627 - 572.65+175.784))
=501.945

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=801.455 - 200.866 - ( 166.73 - max(0, 227.671 - 556.498+166.73))
=433.859

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Vincent Medical Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=69.148/( ( (149.016 + max(180.965, 0)) + (171.145 + max(132.771, 0)) )/ 2 )
=69.148/( ( 329.981 + 303.916 )/ 2 )
=69.148/316.9485
=21.82 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(172.394 + 173.848 + 35.804) - (108.88 + 0 + 92.201)
=180.965

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(163.43 + 170.207 + 0) - (200.866 + 0 + -2.8421709430404E-14)
=132.771

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Vincent Medical Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=79.341/244.616
=32.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vincent Medical Holdings EBIT Related Terms

Thank you for viewing the detailed overview of Vincent Medical Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Vincent Medical Holdings Business Description

Traded in Other Exchanges
N/A
Address
22 Tak Fung Street, Units 1604-07A, 16th Floor, Two Harbourfront, Hung Hom, Kowloon, Hong Kong, HKG
Vincent Medical Holdings Ltd is an investment holding company engaged in the manufacturing and selling of medical devices. The company operates in two segments: OEM (original equipment manufacturing) and OBM (original brand manufacturing). The OEM segment manufactures products as per the customer requirement. The OBM segment includes research, development, manufacturing, marketing, and sales of medical devices under Inspired Medical, Hand of Hope, and Hypnus brands. Its product categories include Respiratory products, Imaging disposable products, Orthopaedic and rehabilitation products, and Others. Its geographical segments are United States, The PRC, Japan, Costa Rica, The Netherlands, Spain, Germany, Hong Kong, Turkey, Canada, India, Thailand, Vietnam and Others.
Executives
Choi Man Shing 2101 Beneficial owner
Liu Pui Ching 2202 Interest of your spouse
Vincent Raya International Limited

Vincent Medical Holdings Headlines

No Headlines